Researchers | Donors | Patients | CRI Leadership
In our “Real Stories” series, we highlight CRI researchers, donors, trustees as well as the patients who’ve benefited from their efforts. We add new profiles of these everyday heroes in the battle against cancer to the site throughout the year.
Past profiles are archived below. Click on their names to read their stories. For the current feature story, go to the main Real Stories page.
Researchers
|
 |
Researcher profile: Dr. Jonathan Cebon
 Clinical investigator Dr. Jonathan Cebon at the Joint Austin/Ludwig Institute for Cancer Research Medical Oncology Unit at Austin Hospital in Melbourne, Australia, is using vaccines to treat melanoma patients.
Read More
|
|
 |
Researcher Profile: Dr. Xingxing Zang
A postdoctoral fellow at Memorial Sloan-Kettering Cancer Center whose discovery of a cellular marker may lead to new diagnostic screens for ovarian and prostate cancer.
Read More |
|
Back to Top
Donors
Back to Top
Patients
|
 |
Patient profile: Tim Stobo
Australian Tim Stobo knew from the public service advisories that malignant melanoma was a growing problem in his country. When the disease struck him, he wanted to fight back, so he enrolled in a CRI/LICR Cancer Vaccine Collaborative clinical trial of a new vaccine to treat melanoma.
Read More
|
|
 |
 Patient Profile: Chrstine Sable
Like most ovarian cancer patients, Christine's disease had progressed before she realized she was sick. In this Q&A, Christine shares how her participation in a CRI/LICR Cancer Vaccine Collaborative clinical trial of a new ovarian cancer vaccine is keeping her alive.
Read More
|
|
Back to Top
CRI Leadership
|
|
Trustee profile: Geoffrey O. Coley
Great-nephew of CRI's founder, Helen Coley Nauts, CRI trustee Geoff Coley is committed to furthering the Institute's mission. "We need to speed up the advancement of new vaccines and therapies so we can begin to treat real patients now.”
Read More
|
|
Back to Top